DexCom Inc. (NASDAQ: DXCM)’s stock price has plunge by -1.82relation to previous closing price of 116.73. Nevertheless, the company has seen a -3.71% plunge in its stock price over the last five trading sessions. Barron’s reported on 10/28/22 that Dexcom Stock Soars on Earnings and Revenue Beat
Is It Worth Investing in DexCom Inc. (NASDAQ: DXCM) Right Now?
The price-to-earnings ratio for DexCom Inc. (NASDAQ: DXCM) is 166.10x, which is above its average ratio. Moreover, the 36-month beta value for DXCM is 1.15. Analysts have varying opinions on the stock, with 17 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
The average price recommended by analysts for DexCom Inc. (DXCM) is $140.81, which is $25.71 above the current market price. The public float for DXCM is 384.65M and currently, short sellers hold a 3.76% of that float. On May 26, 2023, DXCM’s average trading volume was 2.15M shares.
DXCM’s Market Performance
DXCM stock saw a decrease of -3.71% in the past week, with a monthly decline of -8.26% and a quarterly a decrease of 4.11%. The volatility ratio for the week is 3.51%, and the volatility levels for the last 30 days are 2.84% for DexCom Inc. (DXCM). The simple moving average for the past 20 days is -3.97% for DXCM’s stock, with a 6.47% simple moving average for the past 200 days.
DXCM Trading at -2.78% from the 50-Day Moving Average
After a stumble in the market that brought DXCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.36% of loss for the given period.
Volatility was left at 2.84%, however, over the last 30 days, the volatility rate increased by 3.51%, as shares sank -7.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.78% upper at present.
During the last 5 trading sessions, DXCM fell by -3.71%, which changed the moving average for the period of 200-days by +34.65% in comparison to the 20-day moving average, which settled at $118.90. In addition, DexCom Inc. saw 1.21% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DXCM starting from Pacelli Steven Robert, who sale 412 shares at the price of $118.65 back on May 23. After this action, Pacelli Steven Robert now owns 132,274 shares of DexCom Inc., valued at $48,884 using the latest closing price.
Sylvain Jereme M, the EVP Chief Financial Officer of DexCom Inc., sale 2,400 shares at $117.58 during a trade that took place back on May 22, which means that Sylvain Jereme M is holding 74,711 shares at $282,192 based on the most recent closing price.
Stock Fundamentals for DXCM
Current profitability levels for the company are sitting at:
- +13.44 for the present operating margin
- +64.46 for the gross margin
The net margin for DexCom Inc. stands at +11.73. The total capital return value is set at 9.31, while invested capital returns managed to touch 8.99. Equity return is now at value 13.90, with 5.60 for asset returns.
Based on DexCom Inc. (DXCM), the company’s capital structure generated 100.62 points at debt to equity in total, while total debt to capital is 50.15. Total debt to assets is 39.78, with long-term debt to equity ratio resting at 63.42. Finally, the long-term debt to capital ratio is 31.61.
When we switch over and look at the enterprise to sales, we see a ratio of 14.87, with the company’s debt to enterprise value settled at 0.04. The receivables turnover for the company is 4.60 and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.99.
Conclusion
To wrap up, the performance of DexCom Inc. (DXCM) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
